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The chosen topic, coffee consumption and its effects on cardiovascular health can be 
explained by a personal interest and the desire to understand in more depth, the effects 
coffee has on cardiovascular health. The reason for this interest is related to the 
worldwide popularity of coffee as a beverage, along with the conflicting results on the 
research based evidence done over the years about coffee’s effects on health. This 
interest has gradually grown as a result of the polarity of what coffee’s once illustrated 
effects on health was, to what it is today.  Coffee has been gaining popularity as a 
protective entity in cardiovascular medicine. As a result, consumption of coffee is being 
encouraged through the media, especially over the internet on health and lifestyle 
websites.  
The thesis focuses and explores the conflicting evidence on the consumption of coffee 
over three decades, and the role of nicotine on the consumption of caffeine. The thesis 
also focuses on the incriminating evidences between the researches done in the past 
from the research done in the present.  I think it is important to gain knowledge on 
whether there are negative side effects to excessive consumption of coffee, as well as to 
understand why brewing methods play an important role on the effects coffee has on 
cardiovascular health.   
Coffee is the most widely drunk beverage around the world, especially within 
Scandinavia;1 according to the statistics portal for data market, 1211 cups of coffee per 
capita was drank in Sweden alone in 2014, which was highest in the world after Finland 
at 1252 cups of coffee per capita. Norway came in at 5th place with 916 cups per capita 
and Denmark at 6th place with 845 cups per capita in 2014.1  
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The importance to explore the full effects of coffee related health problems, including 
brewing methods, is mainly due to the high consumption rate of coffee around the 
world. In the context of public health, knowing how a popular beverage such as coffee 
effects the cardiovascular risks, can eventually influence mortality rates related to 
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The World Health Organization has claimed that non-communicable diseases kill 38 million 
people each year, and cardiovascular diseases (CVD) related deaths was the number 1 cause.   
Coffee is the most drank beverage all over the world. Researches in the past, had suggested 
that coffee consumption may increase risks of CVD.   
A literature study was performed using online search engines, google scholar and pubmed, 
in order to assess and compare evidence of the effects of coffee on cardiovascular health. 
Searches were done throughout the writing process. Filters were used to make the search 
process easier. Searches were performed according to publication dates between 1st January 
1974 and 31st December 2015. Specific words like ‘coffee’, ‘risk’, ‘cardiovascular diseases’, 
‘brewing methods’, were combined with ‘or’ and ‘and’ during the search process. 
Over the decades, researches acknowledged the consistency of coffee’s role in increasing 
the lipid profile in humans. However, they were able to claim that the brewing methods had 
an important role to the outcome of the results. In more recent times, it has been suggested 
that presences of antioxidants in coffee may have beneficial effects on over-all health of 
individuals. 
There has been extensive research done on coffee over the past 5 decades, and the effects it 
may have on health, with conflicting results. However, it seems that the quantity of 
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1. Rational  
 
Cardiovascular diseases are among the four major non-communicable diseases (NCD) 
responsible for leading causes of death worldwide. According to the World Health 
Organization (W.H.O), 52% of all death in 2012 were NCD related, and 37% of the 52% of the 
lives claimed were due to Cardiovascular diseases.9 
 
Fig 1: Proportion of global deaths under the 
age of 70 years, by cause of death. Estimates from 2012. (WHO. Global status report on 





As reported by the W.H.O, Cardiovascular diseases (CVDs):  
 are the number 1 cause of the global deaths;  
 17.5 million people were estimated to have died in 2012 due to CVD related causes, 
of which 7.4 million were due to coronary heart disease, and the remaining 6.7 
million were cerebrovascular accidents (CVA).  
 Preventable.  
 Population with high risk factors can be managed appropriately if they are detected 
early on.10  
Through the years, risk factors for cardiovascular diseases have been identified as 
preventable and non-preventable. Among preventable causes, cigarette smoking, alcohol 
use, inactivity, and general life style choices were attributable to the significant portion of 
CVD related deaths.10  
In previous years, coffee was identified as a potential culprit to a cause of CVD related 
deaths. However, the results from more recent research favoured coffee as a protective 
agent against CVD.   
The mere contradiction of the earlier research and effects of other factors related to the 
population of coffee drinkers, is something I wish to explore in this thesis. How coffee 
drinking is related to smoking is also explored later on in the thesis, as the relation between 
the two came up as a coincidence while reading papers based on the effects coffee had over 





2. Objective  
 
The objective of this literature study is to assess whether there are any benefits of drinking 
coffee on the cardiovascular health and to briefly analyse the relationship of caffeine to that 
of nicotine.  
3.  Thesis Structure  
The structure of the thesis is gradually built up for the purpose of understanding the thesis 
topic, and to better understand the controversies attached to the research over the years. 
The rational part of the thesis, Chapter 1, gives an overall explanation as to how this thesis 
topic is of importance to public health. Chapter 2 states the objective, and chapter 4 explains 
the literature search strategy, including methods and materials. The definitions and 
clarifications of terms that were stated was also included in this section. In chapter 5, a 
simplified version of the physiology of the cardiovascular system is included along with the 
definition of CVD in accordance to WHO’s definition is given.  
In chapter 6, methods of how the first three Tromsø studies were conducted is explained. 
The reason why this was introduced separately is because the older Tromsø study was 
among the first studies to recognize the importance of brewing methods, and the thesis 
primarily focuses on the evolvement of the idea of the risk factor, being coffee, from the 
past to the present, and what we know now that we didn’t know then.  
The discussion of coffees effect on risk of CVD is found in chapter 7 under the title, “The 
discover of coffee on cardiovascular risks.” Chapter 8 is the result section, found under the 
title, “Recent Research on Coffee and Cardiovascular health.” 
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In chapter 9, the combined effects of coffee and smoking are discussed along with why 
smokers may drink more coffee than none smokers.  
Chapter 10 is the methodological limitations and chapter 11 is the summary and conclusion 
part of the thesis.  
 
4. Method and Materials  
 
A literature study was performed with the purpose to describe the effects of coffee on 
cardiovascular health in humans, by discussing and comparing evidence.  
 4.1 Definitions and clarifications  
Cardiovascular diseases as stated by the World Health Organization2 are;  
“a group of disorders of the heart and blood vessels and include: 
 coronary heart disease: disease of the blood vessels supplying the heart muscle; 
 cerebrovascular disease: disease of the blood vessels supplying the brain; 
 peripheral arterial disease: disease of blood vessels supplying the arms and legs; 
 rheumatic heart disease: damage to the heart muscle and heart valves from 
rheumatic fever, caused by streptococcal bacteria; 
 congenital heart disease: malformations of heart structure existing at birth; 
 deep vein thrombosis and pulmonary embolism: blood clots in the leg veins, which 
can dislodge and move to the heart and lungs.2” 
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Myocardial infractions are more commonly known as heart attacks and cerebrovascular 
incidents are called strokes in layman terms. These are acute events caused by a build-up of 
fatty deposits, calcium and blood clots that block or narrow the arteries, preventing blood 
from flowing to the heart or brain. Strokes can also be caused by bleeding from within the 
brain.2  
In this thesis, cardiovascular diseases do not include the whole array of the definition given 
by the WHO, instead for the purpose of this thesis only, cardiovascular diseases include 
coronary heart diseases, mainly myocardial infractions and coffee drinking as a potential risk 
modifier.  
What is Cholesterol? According to the National Heart, Lung, and Blood institute, cholesterol 
is a substance that is produced by the liver, and is required for the production of some 
hormones, vitamin D and for some substances that help digest food.3  
In the bloodstream, cholesterol is transported in small packages made of lipids (on the 
inside) and proteins (on the outside). These packages are called lipoproteins. The 
lipoproteins are responsible for carrying cholesterol throughout the body. There are mainly 
two types of cholesterols, low density lipoproteins (LDL), and high density lipoproteins 
(HDL). High levels of LDL cholesterol is responsible for the build up of cholesterol in the 
arteries, and is therefore sometimes referred to as “bad cholesterol”. HDL cholesterol is 
responsible for the transport of cholesterol from other parts of your body back to your liver, 
where it is than excreted.3  
The condition in which there is presence of too much cholesterol in the blood is called “high 
blood cholesterol”. Risk of coronary heart disease is greater in individuals with higher levels 
of blood cholesterol, mainly in those individuals with high LDL levels, whereas high levels of 
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HDL lower the chances of coronary heart diseases. High blood cholesterol is problem 
because it usually manifests without any signs or symptoms and is only detected through 
blood testing.3 
Coronary heart disease is the disease of the arteries suppling the heart muscles. According 
to the British heart Foundation, Coronary heart disease is a condition in which there is a 
build up of fatty materials (plaque) within the coronary arteries thereby causing insufficient 
supply of oxygenated blood to the coronary muscles.5 Atherosclerosis is the condition 
caused due to the build-up of plaque within the arteries. Plaque can consist of cholesterol, 
fat, calcium, and other substances found in blood.4 
According to the National Institute of Health (NIH), measuring cholesterol levels are as 
follows;  
 “Total cholesterol–a measure of the total amount of cholesterol in your blood, 
including low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) 
cholesterol. 
 LDL (bad) cholesterol– Low Density lipoproteins, the main source of cholesterol build 
up and blockage in the arteries 
 HDL (good) cholesterol–High Density lipoproteins helps remove cholesterol from your 
arteries 





Table 1: Value of cholesterol levels defined as optimal, near optimal, borderline high, high or 
very high, as a risk factor for cardiovascular disease. (Source: National Heart, Lung and Blood 
institute. Cholesterol Levels: What You Need to Know. 2012 (Cited on 2016 Feb 8). 7(2):6-7. 
Available from: 
https://www.nlm.nih.gov/medlineplus/magazine/issues/summer12/articles/summer12pg6-
7.html ).  
 
What is Coffee?  
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When we refer to coffee, we mean the beverage made of roasted coffee beans. The method 
of roasting and production is not explored in the thesis. However, the method of brewing is 
taken into account, along with additional substances such as sugar and cream added to the 
coffee.  
The coffee beverage is produced by roasting coffee beans before the brewing process. The 
coffee bean is extracted from the fruit of the coffee tree which is referred to as a “coffee 
cherry”.6 
According to the National Coffee Association (NCA), Coffee originates from a plant called 
Coffea, and has 500 genera and 6000 species. However, in the commercial coffee industry, 
only 2 coffee species out of the 6000 are used; Coffee Arabica and Coffee Canephora, also 
known as Robusta.7  
Over 2,000 substances have been found in coffee. Coffee mainly consists of carbohydrates, 
making up for 38–42% of the toasted coffee bean. Lipids and amino acids are the other main 
components found in coffee, making about 20% and 10% in remaining consistency 
respectively. Melanoidins give coffee its brown colour, and make up 23% of the weight of 
the coffee bean. Minerals contained in coffee include, aliphatic and chlorogenic acids, 
trigonellines, and volatile aromas. Caffeine is the most studied alkaloid to be present in the 
coffee bean, making up 1.3 to 2.4% of its weight. Other alkaloids present in coffee, include 
purinic alkaloids- theobromine and theophylline; and pyridine alkaloids- trigonelline.19 
Cafestol and kahweol are the two diterpene molecules found in coffee, which manifest as 
oily droplets in the coffee brew.8 These two diterpenes will be looked at more closely in the 
discussion part of the thesis.  
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Homocysteine: Homocysteine is an amino acid that is produced by the body during the 
methionine cycle, when adenosine is comically broken down into homosysteine. It was first 
discovered in 1932 by Butz and du Vigneaud by chance during their study on insulin.  When 
methionine was heated in sulfuric acid, the methionine transformed into a new amino acid 
that had similar properties to that of cysteine.48,49 Homocysteine levels in the blood, like 
cholesterol levels, have been claimed to be a possible predictor in the out comes in risk of 
CVDs’ by scientists in the past.69 However, it is no longer being considered as an 
independent risk factor.66 More about homocysteine is discussed in a later chapter.  
 
 4.2 Literature search strategy:  
Systematic searches were performed to find relevant background theory that were available 
to identify relevant studies to discuss in the paper. Searches were performed on 
observational studies, mainly prospective cohorts were preferred, using the online search 
engines PubMed, google scholar, and from reference lists of papers that were searched 
during the research process. Filters were used to make the search easier. The following 
words were searched multiple times during the thesis: ‘coffee’, ‘cardiovascular diseases and 
coffee’, ‘homocysteine’, ‘metabolism of coffee’, ‘cholesterol and coffee’, ‘cafestol and 
kaweol’, ‘Tromsø study’, ‘Scandinavia type boiled coffee’.  
 Human studies were mainly used to build up the theory, however animal studies were only 
included when human studies were limited.  
Different sources were used to obtain evidences to support or to disprove the theory and 
claims. Background theory was obtained from reports, text books, and web pages. Reviews 
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were used as research support on background theory when other materials were lacking No 
unpublished literature was used. 
Searches were done several times during the writing process to find theory, and evidence 
showing an effect or no effect. The search criteria were as follows:  
 research papers had to be published between 1 January 1974 and 31 December 
2015. Primary studies done within Scandinavia was preferred since the thesis was 
inspired by the 1st Tromsø studies, it would be easier to compare the older studies 
with newer studies from within the same region, where otherwise cultural and 
lifestyle differences may have altering consequences on the results. Other studies 
and reviews were used to back up claims when necessary;  
 articles describing the brewing methods; 
  both single studies and reviews were used;  
 the primary objective had to concern coffee intake as an exposure and CVD as an 
outcome.  
Search criteria were intended to find articles specific and relevant to the topic. All studies 
discussed in chapters 6 and 7 were published before 31 December 2015. The Tromsø heart 
study from previous decades was the primary study of choice, because the aim of the 
Tromsø Study when it was first initiated in 1974, was primarily to determine the reasons for 
the high mortality of cardiovascular diseases, and to develop ways of preventing CVDs. 
While more recent studies were chosen between 1st January 2000 to 31st December 2015, as 
long as they could be compared to the older Tromsø studies. Differences in the initial 
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research were compared and history of the relationship between cardiovascular diseases 
and coffee was explored.  
Studies preferences were ranked according to geographical locations from most preferred to 
the least preferred in the following order: - Scandinavia; Nordic regions; Western Europe; 
others. The reason for this preference was to minimise bias regarding diet and lifestyle 
associated with different geographical locations, and to make it easier to compare the older 
Tromsø studies with the latest studies on how we used to perceive coffee to what we 
perceive it to now in regards to cardiovascular health and medicine. Only studies published 
in English were used. For the ‘latest research’, papers between 1st January 2000 and 31st 
December 2015 were used.  
The literature sources according to preference in study designs: prospective cohort studies; 
randomized control trials; case control studies; and literature reviews. Although RCTs would 
have been preferable due to the lower chances of bias, for this thesis topic however, cohort 




Materials chosen for the purpose of the thesis were older studies primarily from within the 
population based studies within the Tromsø cohort, between 1970’s and 1999’s. I chose 
these studies because the Tromsø study was among the first cohort studies to recognize the 
effects of the brewing methods involved in the outcome of CVD among coffee drinkers. 
These studies were used as the ‘build up’ material in the thesis, and helped to explore 
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whether coffee was a risk to the outcome, CVD. Newer studies from 2000 January 1 till 2015 
December 31, were used for the purpose of understanding the evolvement of coffee and the 
reported consequences on cardiovascular health, and to compare the outcomes.  
Summary of the materials used:  
Country of Origin of the studies used: Norway, Sweden, United States of America, Australia, 
Netherlands, Italy.   
Study design: Cohort studies, Randomized control trials, Case control studies, cross sectional 
studies, and literature reviews.  
Exposure: Coffee. 
Outcomes: acute myocardial infractions, raised serum lipid profiles.  
Adjusting: smoking.   
Limitations: possible biases present in the study designs used, therefore increasing chances 
for less accurate results.   
The materials used for the thesis is given in more detail in the supplementary part of the 
thesis.   
(Over view of the literature search strategy and characteristics of the studies used are 






5. Cardiovascular Diseases & Health  
The heart is a muscular organ responsible for pumping blood to different parts of the body. 
It is located in the thoracic cavity and consists of 4 chambers, but acts like 2 separate pumps. 
The right side of the heart is responsible for pumping blood from the heart to the lungs, and 
the left side is responsible for pumping blood from the heart to the rest of the body.11 
Deoxygenated blood from the rest of the body is collected in the veins, which transports the 
blood to the right side of the heart. From there, the blood is transported into the lungs for 
excretion of carbon dioxide and is then re-oxygenated. The oxygenated blood is then 
transported to the left side of the heart, where it is then pumped to the rest of the body. 
The heart beats about 60 to 70 times per minute at rest, and increases gradually with 
physical activity.12 Coronary arteries are responsible for supplying the heart muscles with 
oxygenated blood and nutrients and for the excretion of deoxygenated blood from the heart 
muscles. The inner system within the heart that is responsible for supplying the heart 





Fig 2: Anatomy of the Heart. (Image source: Biology for kids (online). Updated 2016 




 Fig 3: The heart as a two 




The World Health Organisation (W.H.O), describes cardiovascular diseases as a group of 
disorders of the heart and blood vessels. These include:  
 coronary heart disease; 
 cerebrovascular disease (CVI- cerebrovascular incidents and CVA- 
cerebrovascular accidents); 
 peripheral arterial disease; 
 rheumatic heart disease (caused by streptococcal bacteria); 
 congenital heart disease; 
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 deep vein thrombosis and pulmonary embolisms.10 
Myocardial infractions(MIs) and CVAs are acute events and are caused by a blockage 
preventing blood from flowing into the heart or brain. Atherosclerosis is a condition 
that is responsible for the occurrences of MIs and CVAs. It is characterized by a build-
up of plaque (fatty deposits) in the inner walls of the blood vessels that supply the 
heart or brain. CVA’s can also be caused by a haemorrhage within the blood vessels 
in the brain or from blood clots. MIs and CVAs are presentes result as acute 
conditions, associated with a combination of risk factors. These risk factors include 
smoking, excessive alcohol intake, unhealthy diet, obesity and physical inactivity, 
hypertension, diabetes and hyperlipidaemia.10  
 
For the purpose of this thesis, incidence of CVA/CVI was not included in the 
investigative process. Occurrence of MI among coffee drinkers was the primary 
objective.  
 
6. Introduction to the Tromsø Study  
This thesis is primarily based on the findings from the older Tromsø studies done 
between 1974 and 1987. The reason why these studies were primarily chosen 
was because the Tromsø study was one of the first studies to recognise the 
effects of brewing methods on the serum cholesterol levels in the study 
participants. University of Tromsø initially funded the project, but over the 
years, other contributions have been made to the project from organizations 
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such as the National Screening Services, the Research Council of Norway, 
Northern Norway Regional Health Authority, Norwegian Council on 
Cardiovascular Diseases and Norwegian Foundation for Health and 
Rehabilitation.13 
 
The Tromsø study was initiated in 1974 in an attempt to help combat the high 
mortality rate of cardiovascular diseases in Norway. Mortality rates due to 
cardiovascular causes was highest amongst the middle-aged population, 
primarily among the Norwegian male population. Norwegian men in the mid 
1970’s, were at a higher risk of dying due to a cardiovascular disease before the 
age of 75 years. Tromsø study was initiated with the goal to determine the 
cause of the high cardiovascular mortality rates, and also to develop ways of  
preventing CVDs.13  
 





The Tromsø Study consists of six surveys that have been conducted in the 
municipality of Tromsø from 1974, and has been an active project since then. 
The thesis uses the first three of the Tromsø Study surveys dating from 1974-
1987, to understand how coffee consumption was related to high cholesterol 
levels, thereby increasing the risk of CVD.   
 
The Tromsø 1, 1974: 8866 men were invited to participate in the first survey, 
between the ages of 20-49. The participation rate was 83%. Questionnaires 
were sent out with the invitation. Questionnaires were pharased into ‘yes’ or 
‘no’ questions, and the participants were asked about their medical history, on 
known diagnosis of cardiovascular diseases and diabetes, or whether they had 
symptoms of cardiovascular diseases, smoking habits and physical activity 
during work and leisure time. The participants were interviewed, and 
measurements of height, weight and blood pressure, along with  blood samples 
for measurents of serum total cholesterol, triglycerides and haemoglobin, were 
taken.73 In the first study they discovered the effects of high density lipoproteins 
in the prevention of myocardial infractions.73 





The Tromsø 2 study, 1979-1980: Tromsø Study 2 took place between 1979 to 
1980. A total of 16 620 people took part in the second survey, which included 
8477 men between the ages of 20-54 years, and 8143 women between the ages 
of 20-49 years. The men who were invited to participate in the first Tromsø 
Study were reinvited to participate in the second survey. Participation rate was 
74%. A questionnaire similar to the first survey about diagnosed cardiovascular 
diseases and diabetes, current symptoms, and life style habits, was sent out, 
along with an invitation to measure height, weight, blood pressure, serum total 
cholesterol, HDL cholesterol, triglycerides and blood sugar level. People that 
attended the study received a second set of questionnaire regarding their diet, 
medical histories including family medical histories, and social conditions. Based 
on the results from the Tromsø 2 study, it was discovered that the consumption 
of coffee increased serum cholesterol levels.74  





The Tromsø 3 study, 1986-1987: The third survey of theTromsø Study was taken 
between 1986-1987. 21 826 people participated in the third survey, among 
which 10 963 were men between the ages of 20-61, and 10 863 women 
between the ages of 20-56.  This time an additional 10 persent of the population 
between the ages of 12-19 were randomly selected, and those who had 
previously participated in the family intervention study, which was a study that 
had been carried out shortly after the second Tromsø, were also included. 
Similar questionnaires as the first two studies were sent out, with additional 
questions on coffee consumption habits, salty food intake and fat preference in 
the diet, along with an invitation to measure height, weight, blood pressure, 
serum total cholesterol, HDL cholesterol, triglycerides and gamma-
glutamyltransferase (gamma-GT), and a simple electrocardiogram was carried 
out. Those that attended the study got a second set of questionnaires to fill out, 
including general health, medical history including the family medical history, 
medications, diet, lifestyle and social conditions. The Tromsø 3 study, confirmed 
that unfiltered coffee increased serum cholesterol. It was also found that people 
who developed myocardial infarction had higher levels of homocysteine than 
healthy people.75 







7. The discovery of the effects of coffee as a 
cardiovascular disease risk factor 
 
From an earlier study based on the Tromsø study 1, Dag S. Thelle and his 
colleagues, noticed the presence of a positive correlation between mortality due 
to cardiovascular diseases, high serum cholesterol and smoking,14 which were 
risk factors that were already recognized long before the Tromsø study. At the 
time, it was believed that the reason for higher mortality due to CVD among the 
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population in Northern Norway was due to high serum cholesterol levels, and 
higher percentage of smokers compared to other regions in Norway. Smoking 
was singled out as the cause for high serum cholesterol levels leading to CHD 
related deaths.14  
 
Førde OH et al. conducted a 10week experiment after the second Tromsø study 
survey. The objective of Førde’s experiment was to assess the effects of coffee 
consumption and coffee brewing methods on serum cholesterol levels.15 The 
trial consisted of 33 men with hypercholesterolaemia, who were randomly 
assigned to 1) continue drinking boiled coffee as per usual; 2) stop drinking 
coffee for the whole duration of the experiment (10 weeks);  3) stop drinking 
coffee for the first 5 weeks, after then start drinking boiled coffee again for 
another 5 weeks; and 4) stop drinking coffee for the first 5 weeks, then start 
drinking coffee again, but only filtered coffee.  







A positive correlation was found between coffee consumption and high serum 
lipid concentrations.15 They observed fluctuations of serum cholesterol levels 
with different levels of coffee consumption. It was suggested that the brewing 
methods could be an important contributing factor to the observed increase in 
the serum total cholesterol levels in the study participants. Cholesterol 
concentrations dropped in all subjects who were told to stop drinking coffee for 
the first of the five weeks. Those that abstained from coffee drinking for a full 
duration of the study (which was 10 weeks long), noticed a continuous decline 
in serum lipid concentrations while the subjects that went back to drinking 
boiled coffee after 5week duration, an incline in the cholesterol concentrations 
was observed. However, in those that drank filtered coffee, the serum 
cholesterol levels remained the unchanged after recommencing to the 
consumption of coffee.15 During the experimental period, the participants were 
encouraged to eat their normal diets. Participants were chosen specifically 
because they showed no improvements in their cholesterol levels for 3 years 
since the 1st Tromsø study survey, and could not reduce their cholesterol levels 
through diet. However, the experiment failed to give a clear deduction of to 
what extent coffee consumption may have been responsible for the increase in 
cholesterol levels related to the brewing methods.15   
 
Here after, studies aimed to take a closer look at the effect coffee consumption 
had on cardiovascular disease risks. It was observed that coffee consumption 
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was positively associated with higher total cholesterol and triglycerides in both 
genders. In the study by Dag S. Thelle et al, “Doses Coffee raise serum 
cholesterol?”, based on the Tromsø study 2, it was found that the consumption 
of coffee was positively associated with higher levels of total cholesterol in both 
gender groups, and an inverse relation to HDL levels was observed in women.16 
The relation between coffee and cholesterol levels in the blood remained 
statistically significant (P<0.0001 in a covariance analysis),even after adjusting 
for age, body mass index (BMI), physical activity, smoking, and alcohol 
consumption. The total cholesterol level was 5.56±0.05 mmol per liter in men 
drinking less than one cup of coffee per day, and 6.23±0.03 mmol per liter in 
participants who consumed more than nine cups per day. For women total 
cholesterol level was 5.32±0.05 mmol per liter in those that drank less than one 
cup of coffee per day, and 5.92±0.04 mmol per liter in those that drank more 
than nice cups of coffee per day.  The conclusion made from this study was that 
coffee consumption was the major contributing factor for the variations in the 
levels of total cholesterol.16 However, in this study, they failed to investigate the 
brewing methods used for coffee among the study participants.  
 
Due to the popularity of coffee in all of Scandinavia, the effect of coffee on 
cardiovascular disease risk began to be questioned in more frequency. It was 
not long after the 2nd Tromsø study, researchers considered the effects of coffee 
in relation to the brewing methods. This took effect in Tromsø study 3, where 
brewing methods of coffee was investigated. Kaare Bønaa, Egil Arnesen, Dag 
Steinar Thelle, and Olav Helge Førde, in their study “Coffee and Cholesterol: Is it 
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all in the brewing,” found that boiled coffee consumption was as important as 
age of the participants, in determining the serum cholesterol concentrations.  
Boiled coffee consumption was associated with high cholesterol levels.17  
 
It wouldn’t be long until researchers would come up with the question of 
whether coffee drinkers in general had an unhealthy life style to begin with. In 
one such study, it was found that coffee drinkers (mainly women and younger 
men) were less likely to exercise, and 75% of the population that drank more 
than 8 cups of coffee were also smokers. It was indicated that among the 
smokers, high coffee consumption was associated with a higher cigarette 
consumption, and a negative correlation between fruit and vegetable 
consumption with coffee consumption was visible.18   
 
In the Monitoring of Trends and Determinants in Cardiovascular Disease 
(MONICA) study, conducted in Northern Sweden, B.Lindahl et al., reported that 
participants who drank boiled coffee had significantly higher serum cholesterol 
levels than those who drank filtered coffee. It was further reported that those 
who consumed filtered coffee also consumed more fat in their diet. However, 
after adjusting for those who consumed more fat in the filtered coffee group, 
using statistical analysis, a linear correlation between boiled coffee consumption 
and serum cholesterol levels was observed. They ultimately concluded that 




Based on the evidences of from the Tromsø and the MONICA studies, regarding 
coffee consumption and cardiovascular health, it was reasonable to question 
the association between coffee intake and the risk of CVD, and lifestyle in 
general. However, it has been evident from some of these studies, that the 
brewing methods were an important influence to the outcomes, and therefore 
needed to be investigated upon. When investigating the effects of coffee on the 
cardiovascular disease risk, it has been indicated that coffee drinkers are also 
heavy smokers and probably have an unhealthy life style, and coffee alone may 
not be the contributing factor. There may also be a correlation between the 
preference of brewing methods used, daily lifestyle choices, and socioeconomic 
conditions that contributes to these risks.  
 
7.1 Mechanism of action of caffeine in the human body 
Caffeine is also known as 1,3,7-Trimethyl-2,6-dioxopurine or 1,3,7-
trimethylxanthine23. It is the most widely consumed central-nervous-system 
stimulant and is naturally found in coffee, tea, cocoa among others.20, 21,22 
Coffee contains 71-220mg/150ml of caffeine.24 As mentioned before coffee 
arabica (Coffea arabica) and robusta (Coffea canephora) are the two main 
commercial coffee types drank around the world. Caffeine content in coffee 
arabica ranges from 71 to 120 mg per cup (in a standard 150ml cup), and 




 Caffeine acts as a central nervous system stimulant, relaxes smooth muscle, 
stimulates cardiac muscle, and stimulates diuresis. On a cellular action level, 
caffeine has been observed to inhibit cyclic nucleotide phosphodiesterases, 





 Fig 4: Caffeine breaks down into paraxantine, theobromine and theophylline 
during metabolism. (Effects of caffeine. Cited on 2016 Mar 11. Available from:  
http://udel.edu/~danikoll/metabolism.html).  
 
Within the human body, caffeine is metabolized into Paraxanthine, 
Theobromine, and Theophylline. There are more than 25 metabolites of coffee, 
three main already mentioned above.25 In humans approximately 3% of 
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ingested caffeine is excreted, while the remaining 97% is completely 
metabolized.26 The main route of metabolism in humans takes place in the liver, 
and is initiated by the enzyme CYP1A2. The final product of caffeine metabolism 
yields paraxanthine as the main product and makes up for approximately 80% of 
the total by-product.  
Fig 5: Caffeine pathway during metabolism. (Thorn Caroline F, Aklillu Eleni, 
McDonagh Ellen M, Klein Teri E, Altman Russ B. "PharmGKB summary: caffeine 
pathway"Pharmacogenetics and genomics (2012). Cited on 2016 Apr 14. Copy 
rights by PharmGKB 2001-2016. All rights received and granted to use from the 
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purpose of the thesis by PharmGKB and Stanford University, 2016 Jun 14. 
Available from: https://www.pharmgkb.org/pathway/PA165884757  ).  
 
There are 5 main metabolic pathways for the metabolism of caffeine in humans. 
Out of the 5, 3 of them involve demethylization of N-3 to form Paraxanthine, N-
1 to form Theobromine, and N-7 to form Theophylline again. In the liver, the 
hepatic cytochrome P-450 (CYP), an isoenzyme, metabolizes the caffeine 
through the process of demethylization into paraxanthine (85%), theobromine 
(12%), and theophylline (4%). The 4th pathway involves C-8 hydroxylation to 
form 1,3,7-trimethyluric acid. The remaining caffeine that is not degraded, is 
eliminated via the renal system.18,25 
 
The xanthine derivatives act as an adenosine receptor antagonist,inhibit cyclic 
nucleotide phosphodiesterase activity, mobilize calcium, and inhibit monoamine 
oxidase activity.25,27,28 Caffeine is responsible for antagonising the adenosine 
receptor in the brain, kidney, cardiovascular system, respiratory system, 
gastrointestinal system, and the adipose tissues.25,29  
 
7.2 How Cafestol and kahweol raise serum cholesterol  
Cafestol and Kahweol are fat-soluble compounds called diterpenes found in 




Fig6: Molecular structure of Kaweol and Cafestol. (Validation of near-infrared 
spectroscopy for the quantification of cafestol and kahweol in green coffee - 
Scientific Figure on ResearchGate. (cited on 2016 Mar 18). Available from: 
https://www.researchgate.net/273544323_fig1_Fig-1-Structural-formulas-of-
cafestol-A-and-kahweol-B  ).  
 
Naturally, the concentration of cafestol and kahweol vary depending on the 
coffee species. Coffee Arabica contains more of both the diterpenes than 
Robusta. Coffee Robusta contains only half of the content of cafestol as coffee 
Arabica, and almost no kahweol.30  
 
Experiments with the two diterpens have proved that cafestol is responsible for 
raising serum cholesterol levels more potently, while kahweol does not raise 
serum cholesterol levels as much.30,31,32,33 Experiments involving brewing 
methods have provided evidence that cafestol and kahweol do not pass through 
the paper filter.17,35,36 This explains why Scandinavian boiled coffee, Turkish 
coffee, espresso coffee, and French press (cafetière) coffee, contain higher 
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levels of cafestol and kahweol compared to filtered coffee, percolated coffee or 
instant coffee.  
 
Arild C. Rustan et al. concluded based on their findings, that coffee diterpenes 
cafestol and kahweol decreased the binding, uptake, and degradation of LDL in 
human hepatoma cells. Their findings suggested that the cholesterol-raising 
effects of cafestol and kahweol involved the downregulation of the hepatic LDL 
receptors by posttranscriptional mechanisms.31 
 
Sabine M. Post et al., in their study using rat hepatocytes, were able to 
determine how cafestol and kahweol increased serum cholesterol levels in 
humans.32 It was found that cafestol suppressed bile acid synthesis by a direct 
inhibitory effect on cholesterol 7α-hydroxylase activity and by downregulation 
of mRNA of cholesterol 7α-hydroxylase and sterol 27-hydroxylase. LDL-receptor, 
HMG-CoA reductase, and HMG-CoA synthase mRNA levels were downregulated 
simultaneously with the decrease in bile synthesis. Cafestol reduced bile acid 
synthesis more potently than the mixture of cafestol and kahweol at the same 
concentration. The down regulation of LDL-receptors in hepatocytes and the 
decrease of bile acid synthesis after the consumption of boiled coffee, was 
presumed to have led to the increase of serum cholesterol levels in the blood.  
 
The study by Marie-Louise Ricketts and colleagues, was an in vitro 
experimentation, and an in vivo study on APOE3Leiden transgenic mice, which 
led to the conclusion that mechanism by which cafestol rose serum cholesterol 
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in humans involved a gene called fibroblast growth factor 15 or FGF 15. Cafestol 
activated farnesoid X receptor (FXR), induced FGF15, which reduced the effects 
of three liver genes that regulate cholesterol levels.33 The mechanism of how 
cafestol raises serum cholesterol in humans is illustrated in figure 7: 
 
 
Fig 7: Metabolic involvement of coffee’s cholesterol in increasing cholesterol 







 “1) Coffee containing cafestol is ingested and passed along into the stomach 
and small intestine. 2) In the small intestine cafestol activates the nuclear 
hormone receptors, farnesoid X receptor (FXR) and  pregnane X receptor (PXR). 
IBABP is induced by cafestol in a FXR-dependent manner, further increasing the 
transportation of bile acids into the portal circulation. Upon activation of PXR, 
cafestol induces the expression of Cyp27A1 and ABCA1, resulting in an increase 
in the efflux of cholesterol into the portal circulation. Cafestol also induces 
Cyp3A11 and GSTμ1 gene expression via PXR, leading to an increase in 
detoxification. Cafestol acts via both FXR and PXR to induce FGF15, which signals 
to the liver to repress bile acid synthesis. 3) In the liver, Cyp7A1, Cyp8B1, and 
NTCP expression is repressed via FXR, thereby reducing the synthesis of bile 
acids. The direct regulation of such FXR and PXR target genes in the intestine 
combines with indirect effects in the liver to contribute to the cholesterol-raising 
effect of cafestol in humans.”33 
 
In another experiment, Bente Halvorsen et al, explored the effects of a coffee 
lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. They 
concluded that cafestol decreased the binding, uptake, and degradation of LDL 
in human skin fibroblasts (HSF), decreased the LDL receptor protein level, 
reduced cholesterol synthesis and increased the cholesterol esterification. Their 
findings suggested that the mechanisms responsible for the cholesterol-raising 
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effects of cafestol involve a post-transcriptional down-regulation of the LDL 
receptor.34 
 
7.3 Homocysteine; what is it; how is it involved in the 
metabolic process; and how is it related to 
cardiovascular diseases and coffee? 
Homocysteine is an amino acid in the body which is formed as an intermediate 
product during the metabolism of methionine into cysteine.48,49,50  
 
  Fig8: Molecular structure of 
homocysteine. (Internet source. Cited on 2016 May 14. Available from: 
http://www.wiley.com/legacy/college/boyer/0470003790/cutting_edge/homoc
ysteine/homocysteine.htm).   
 
Homocysteine was first discovered by Butz and du Vigneaud in 1932. They 
heated methionine, an amino acid, in sulfuric acid, which changed the 




Homocysteine is not found in the diet, but instead is produced in the body 
during the metabolic process of methionine. In recent years, they have 
discovered that the B group of vitamins, vitamin B6, B12 and B8 (folic acid), play a 
part in the homocysteine production cycle.48,50   
 
It was discovered that there were inborn errors in some individuals, perhaps a 
gene with an abnormal mutation during the metabolism of methionine leading 
to the accumulation of homocysteine within the body which lead to a rare 
disease called homocystinuria. This was believed to have  led to some people 
being at a at greater risk of CVD than others, regardless of age or cholesterol 
level as a factor.51 During the metabolism of methionine, homocysteine was 
identified as an intermediate within the cycle, and the enzymes within the cycle 
required the group B vitamins to act as cofactors to enable proper 
functionality.50,51 However the genetic defects in vitamin cofactors, which 
include vitamin B6, B12, and folate, and nutritional deficiency of B12 and folate, 
was discovered to have led to abnormal homocysteine accumulation within the 
body.51 
 
During the metabolism of proteins, the protein molecule is broken down into 
two amino acids. One of these two acids is methionine which breaks down to 
form homocysteine. Once formed homocysteine is removed by a process called 
remethylation, which involves folic acid and vitamin B12 to act as cofactors in 
the reaction. Another way homocysteine can be removed from the body is 
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through the transformation of homocysteine to cysteine through 
transulfuration.50,52  
 
Fig 9: Homosysteine place during metabolism of proteins. (Internet source. Cited 




Caffeine has been suggested to be partly responsible as the component in 
coffee, and not coffee itself, as the factor that influences the rise in 
homocysteine levels in the blood after consumption.71 Chlorogenic acid is the 
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other component found in coffee, an ester of caffeic acid, that has been 
suggested in raising homocysteine levels after consumption.56  
  
The research on the relation between coffee’s role in elevation of homocysteine 
levels in the blood, is still sparse. There is more research being done on 
homocysteine independent of coffee.  
 
Previously, high levels of homocysteine in the blood had been linked to 
cardiovascular diseases. It was believed that elevated total homocysteine 
increment elevated the coronary artery disease (CAD) risk, and folic acid intake, 
as a preventive measure, was believed to help in the reduction of total 
homocysteine levels.69 
 
 In Norway, the Hordaland Homocysteine Study was one of the first to find a 
rather strong association of homocysteine in serum with established CVD risk 
factors, suggesting that homocysteine could perhaps have a causal role in the 
development of CVD.47 The finding was regarded as very important, particularly 
in light of new interventions for the prevention of CVD.  
 
Arnesen E et al. examined the association between homocysteine and coronary 
heart disease (CHD) among the participants in the third Tromsø health study.68 
They found that serum total homocysteine level was an independent predictor 
of the risk of myocardial infarction in the general population, but the predictive 
value of homocysteine was lower than that for total cholesterol, smoking and 
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HDL cholesterol. Threshold levels above which serum homocysteine was 
associated with CHD events was not found in the study. 
 
In a small clinical trial Esposito F et al., tried to determined the effects of  Italian-
style coffee consumption on the plasma concentration of glutathione and 
homocysteine. They were unable to detect any significant rise in homocysteine 
levels in the blood, from drinking five cups of coffee per day for one week.70 
Although the trial was short and small, the amount of coffee consumed seemed 
to not have affect on the homocysteine levels in the blood of the participants. In 
some of these studies, the casual relationship of the quantity of coffee 
consumed to that of the increase of the level of homocysteine, when observed, 
seem not to have been taken into consideration about whether drinking coffee 
only temporary increases homocysteine for a duration, or whether it effects 
levles in a continuous consistent manner.  After these studies, question still 
remains as to whether healthy subjects with increased homocyteine levels 
affects the cardiovasucular system in the same way as it would in prediagnosed 
patients with an underlying health condition or oxidative diseases.   
 
Homocysteine is not a product that can be consumed to increase its levels in the 
body, unlike sugar or fat. Since homocysteine is produced by the body during 
the metabolism of the amino acid methionine, it could be related to other 
factors that increase its presence in the blood such as during oxidative stress, 




Homocyteine is not  regarded as an ‘independent risk’ factor for CVD. In  more 
recent years it has been acknowledged as one among many of the biomarkers, 
which are consequences of other risk factors and early stage of CVD.66  In 
theory, homocysteine could affect the cardiovascular system through its 
atherosclerotic properties on the coronary blood vessels, but it has not been 
found to have the role as a cardiovascular disease risk factor on its own.66 
Furthermore, there is no support for the hypothesis that interventions to lower 
blood levels of homocysteine, have any protective effect on cardiovascular 
health, or reduce risk of cardiovascular disease.67  
 
8. Results: Recent Research on Coffee and 
cardiovascular health 
Analysis of the adverse effects of coffee on cardiovascular health from 
epidemiological studies conducted in the 70’s and 80’s, researchers were able to 
claim that method of brewing coffee was important to these risks. Boiled coffee, 
led to the increase in serum cholesterol, however filtered coffee or instant 
coffee seemed not to be harmful in the same way. In fact, the opposite seemed 
to have led to be true. Coffee consumers seemed to benefit from drinking 
filtered coffee,45 however some have argued that boiled coffee despite its 
cholesterol raising properties may still be beneficial to diseases causing 
oxidative injuries too.63 This is because coffee contains other components that 
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that exhibit antioxidant activities like heterocyclic compounds that seems 
beneficial to cardiovascular health .63 
 
By the 90’s, some researchers conducted studies that led to the conclusion that 
coffee may have affected mortality due to coronary heart diseases ‘over and 
above’ its effect on raising cholesterol concentrations.41 However in such 
studies, brewing methods were not taken into account. Other researchers 
specifically studying the effects of Scandinavian type boiled coffee were able to 
conclude that boiled coffee contained lipids that were able to raise the blood 
cholesterol levels in the body.42,44 
 
Boiled coffee is a popular beverage in rural areas especially in the north, both in 
Norway as well as in Sweden, and has since been recognised to raise blood 
lipids, which is a risk factor for acute myocardial infractions (MI). 
 
 In a more recent nested case-referent study led by a team of Swedish 
researchers in northern Sweden, L.M Nilsson et al investigated the relation 
between consumption of filtered and boiled coffee to the risk of first MI. They 
were able to find a positive association between risk of first myocardial 
infraction (MI) and consumption of filtered coffee among the male population, 
and similar risks for women who consumed boiled coffee.38 The study subjects 
included 303 men and 72 women. They took 1293 matched referents from the 
population-based Northern Sweden Health and Disease Study. A food frequency 
questionnaire was used to ask about coffee consumption, and risk estimates 
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were calculated by conditional logistic regression. They found a positive 
association between consumption of filtered coffee and MI risk in men [odds 
ratio for consumption ≥4 times/day versus ≤1 time/day 1.73 (95% CI 1.05–
2.84)]. Similar associations was observed in women who consumed boiled 
coffee instead of filtered coffee, [odds ratio 2.51 (95% CI 1.08–5.86)]. However 
these results were no longer statistically significant for women after they had 
adjusted for smoking, postsecondary education, hypertension, and sedentary 
lifestyle. They were able to conclude that filtered coffee was positively 
associated with risks of first MI in men, but was statistically insignificant for 
women who drank boiled coffee.38  
 
 In another similar study from Sweden, N.Hammar et al evaluated how much of 
an influence filtered and boiled coffee consumption had on the incidence of first 
nonfatal myocardial infarctions. The study was obtained from two population-
based case–control studies, one from Stockholm and the other from 
Västernorrland. The study subjects consisted of 45-70 year olds without a 
previous myocardial infraction, and were living in Stockholm between the years 
1992-93 men, or women between 1992-94 (the Stockholm Heart Epidemiology 
Programme - SHEEP), or 45-65 year olds living in Västernorrland between 1993-
1994 (Västernorrland Heart Epidemiology Programme - VHEEP). New cases of 
first myocardial infarction in SHEEP and VHEEP were identified from coronary 
and intensive care units at the department of internal medicine at the 
emergency hospitals within the two counties, hospital discharge registers, and 
death certificates from the Swedish National Cause of Death Register. The 
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diagnostic criteria for myocardial infarction were based on typical symptoms, 
changes in blood levels of the enzymes CK and/or LD, typical ECG changes and 
autopsy findings stating signs of recent myocardial necrosis. Each case was 
matched with a control selected from the study base, together with disease 
incidence, age, sex and place of resisdency of the case. Cases of first nonfatal 
myocardial infractions were identified as those who survived more than 28 days 
after disease onset. Depending on the type and quntity of coffee consumed, the 
participants were divided into 13 groups. Statistical analysis was performed, and 
the odds ratios were estimated separately for men and women through logistic 
regression with adjustment for age and hospital catchment area. There were 
1643 nonfatal cases of first myocardial infarctions, 1171 were men and 472 
women. Most of the participants consumed filtered coffee (95%).  The male 
participants’ who reported coffee consumption of >= 7–9 dL day−1 showed an 
increased incidence of first myocardial infarction, independent of the brewing 
methods used. Adjustments were made for smoking since smokers tended to 
drink more coffee overall. Interestingly enough, "men who did not drink coffee 
showed a tendency towards a slightly increased incidence of myocardial 
infarction compared with consumers of 3 dL day−1 of filtered coffee or less.”39 
There were no clear association between consumption of filtered coffee and 
myocardial infraction among women, however consumption of boiled coffee in 
women tended to give odds ratios suggesting a possibly increased incidence (RR 
was 4.97 at 95% CI in those that drank >9 cups of boiled coffee per day). They 
were able to conclude that consumption of boiled coffee may result in an 
increased incidence of first nonfatal myocardial infarction, however 
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consumption of more than 7 dL of filtered coffee per day would still increase the 
incidence in men.39 
 
Table 7: SHEEP VHEEP Study: Relative risk of first nonfatal myocardial infarction 
for subjects with consumption of boiled coffee compared with subjects with 
consumption of filtered coffee. (cited on 2016 June 24).  
 
 
Trine Ranheim and Bente Halvorsen in their review63, mention that moderate 
daily filtered coffee consumption was not associated with any adverse effects 
on cardiovascular outcomes. They were able to provide sufficient data to 
support their theory on anioxidant activities, which seemed to have an inverse 
assosiation with the risk of type 2 diabetes mellitus as well. Ranheim and 
Halvorsen used Chuyen NV’s work on ‘Maillard reaction and food processing’,  
as a source to indicate that melanoidins exhibited strong antioxidant activity, 
while they mentioned that Borrelli RC et al, Shizuuchi S and Hayase F were able 
to show that melanoids also inhibited lipid oxidation. Ranheim and Halvorsen 
mention Azam S et al. work on anioxidents present in coffee in their paper 
‘antioxidant and prooxidant properties of caffeine, theobromine and xanthine,’ 
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to acknowledge that, “When coffee drinks were examined for antioxidant 
properties, measured as DNA-protection through quenching of hydroxyl radical 
generating systems, caffeine and its metabolites, theobromine and xanthine, 
appeared to possess strong DNA-protective effects.” They were able to put forth 
several other studies that were able to make a connection to coffees antioxidant 
properties to make the argument that coffee could possibly prevent diseases by 
antioxidative effects. One such study they put forth was a study by Yukawa et al. 
on healthy men, who were asked to drink 24g of coffee per day for one week, to 
observe how coffee affected LDL oxidative susceptibility. They mention that 
Yukawa et al. observed that coffee consumption had significantly reduced the 
susceptibility of LDL oxidation, which was similar to what another researcher, 
Richelle et al., had also studied on the relative antioxidant activity of coffee, tea, 
and cocoa using an in vitro LDL oxidation model. They were able to claim that 
the beverages contained polyphenols with high antioxidant activities, especially 
in coffee. Ranheim and Halvorsen claimed that from “these studies it could be 
indicated that regular coffee ingestion may favourably affect cardiovascular risk 
status by modestly reducing LDL oxidation susceptibility.” They were able to 
conclude that coffee, depending on the brewing methods, raised cholesterol 
levels due to reduced clearance of cholesterol-rich lipoproteins together with 
increased secretion of triacylglycerol-enriched lipoproteins (VLDL), but its 
antioxidant properties were still beneficial to the health of individuals in 




In eastern Finland, P Kleemola et al. studied the the relation of coffee drinking 
with fatal and nonfatal coronary heart disease (CHD) and all-cause mortality.40 
The prospective cohort study included 20 179 participents that were selected 
randomly. The participants included both men and women between the ages of 
30-59 years.  The baseline examination included habitual coffee drinking, 
behavior, risk factors of CHD, and medical history. The study participents were 
followed for 10 years using the national hospital discharge and death registers. 
By using the analyses of variance, they were able to test the differences in the 
mean values of cardiovascular risk factors, and the Cox proportional hazards 
model was used to preform the multivariate analyses. They used the same 
model to calculate the estimate of the relative risks and their 95% confidence 
intervals. Coffee drinking was used  as a dummy variable at 4 drinking levels. 
Moderate drinking level was used as the baseline level and was defined as, 1 to 
3 cups of coffee intake daily. The model also included the known cardiovascular 
risk factors such as smoking, serum cholesterol level, BP, and history of MI. 
Adjustments for age was made and the SAS statistical program was used to 
perform the statistical analyses. It was discovered that men drank heavier 
amounts of coffee than women, and older participents were more likely to drink 
more coffee than their younger counterparts. They found that men who drank 
more coffee were more likely to be smokers and have higher serum cholesterol 
levels aswell. Nondrinkers were found to have slightly lower BMI and systolic 
blood pressure than coffee drinkers. Light coffee drinking, defined as 1-3 cups of 
coffee per day, had slightly higher diastolic bloodpressure than noncoffee 
drinkers, moderate coffee drinkers (4-7 cups daily), or even heavy coffee 
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drinkers ( >7 cups daily). The prevalance of coffee drinking to that of higher 
serum cholesterol levels and smoking in women, were directly propotional. 
Women who were heavrier coffee drinkers were also more likely to be smokers 
and have higher serum cholesterol levels. A tendency for increase in blood 
pressure increased also with increase in coffee intake until >7 cups. The BMI in 
women was lowest in people who were moderate coffee drinkers, but increased 
in the higher coumption group of coffee drinkers. They found that the risk of 
nonfatal MI in men was not associated with coffee drinking. Risk ratios of CHD 
and total mortality was higher among noncoffee drinkers than coffee drinkers 
after adjusting for smoking, serum cholesterol , BP, and previous MI. In women, 
no significant association between coffee drinking and CHD mortality was found.  
In their multivariate model, they found that the risk ratio of nonfatal MI in 
nondrinkers was higher than in coffee drinkers. With increase in coffee intake, a 
decrease in total mortality was observed with women, and was statistically 
significant ( P=.07, multivariate model). The authors claimed that no association 
was found between coffee drinking and the risk of nonfatal MI. Noncoffee 
drinkers were more likely to die due to a coronary heart event than those who 
drank coffee. The association between coffee drinking and total mortality in 
men, was the lowest in the group who drank moderate amounts of coffee. In 
women, coffee drinking was inversely propotional to total mortality, that is, with 
increasing coffee drinking, incidence in total mortality derceased. They were 





Australian researchers OB Tofler et al. mention that depending on the study 
design, the role of coffee consumption in the onset of myocardial infarction 
varies.43 Him and others40 have reported that reviews of published reports show 
that cohort data suggests very little risk of coronary heart disease among 
habitual coffee drinkers, but case-control data suggests that risks for CVD 
increases in people that drink more than five cups of coffee per day. To test the 
theory, Tofler et al. conducted an experiment in the coronary care unit at the 
Royal Perth Hospital in Australia. They tired to obain  information on the 
lifestyle and habits of the study participants, including coffee consumption, of 
those who had been admitted with chest pain. Questionnaires was given to the 
patients and details were self reported. A similar questionnaire was given to 
people at the cardiology out patient clinic. They found that among the 182 
patients with myocardial infarction or unstable angina, and 185 patients with 
chronic stable coronary heart disease, from the Cardiology Outpatient Clinic, 
was that people with acute coronary syndromes drank more than five cups of 
coffee per day (18 vs 7.5%; P = 0.003). After adjusting for age, smoking status, 
hypertension, dyslipidaemia and diabetes, the odds ratio was found to be 2.51 
(95% CI 1.43,4.43; P = 0.021). They came to the conclusion that according to 
their case-control study, there was evidence of an increase in the risk of 
myocardial infraction or unstable angina among those who drank more than 5 
cups of coffee per day.43  
 
The reason why the results from case control studies might differ to that of 
cohort studies could be due to poor control for confounding among case control 
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studies.40 It has been suggested that the discrepancy between the findings from 
cohort and case-control studies may be explained if coffee was to act as a 
triggering event in people with chronic CHD which led to MI, instead of it being a 
risk factor for CHD.40  
 
In one RCT, Urgert et al., experimented on twenty-six healthy volunteers (10 
men and 16 women) between the ages of 18–53 years. They were asked to 
consume 1 L/d of paper-filtered coffee brewed with 70 g regular ground beans 
or no coffee for 4 weeks, each in a randomized crossover design.46 The aim of 
the experiment was to find out whether heavy filtered coffee drinking is related 
to high homocysteine concentrations. They reported that duing the coffee 
drinking period of the experiment, heavy coffee drinking raised the fasting 
plasma concentration of total homocysteine in 24 of 26 subjects. The mean 
homocysteine level rose by 1.5 ± 1.5 mol/L (95% CI: 0.9, 2.1 mol/L) after 3–4 wk 
of coffee drinking. The outcome was not affected by the treatment order. The 
mean increase was 1.8 ± 2.2 mol/L in subjects who were switched from no 
coffee to coffee (n = 15) and 1.3 ± 0.8 mol/L in those switched from coffee to no 
coffee (n = 11).  Coffee drinking increased plasma total homocysteine by 22 ± 
23% after 2 weeks and by 18 ± 16% after 3–4 weeks (range: 2% to 67%). They 
noticed that there was no significant difference in the circulationg B vitamins 
during the treatment period. From this study, drinking large quantities of paper-
filtered coffee raised fasting plasma concentrations of total homocysteine in 
healthy individuals over a period of time.46 In an older population based study 
conducted in Norway, Nygård et al. were able to claim that elevated plasma 
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total homocysteine level was associated with major components of the 
cardiovascular risk profile, including gender, age, smoking habits, cholesterol 
level, and level of physical activity.47  
 
Homocysteine has not been classified as a cardiovascular disease risk factor 
under stratification guidelines, this is because homocyteine is not regarded as 
an independent risk factor for CVD.66 Ganguly and Alam, from their review, 
mention that from the work of other authors on homocysteine research, have 
indicated that there is some relationship towards moderately elevated 
homocysteine levels and the risk of CVD, but this could be due to a secondary 
consequence leading to atherosclerosis, which could increase risks of a 
cardiovascular events in patients.66 However, there is still not enough evidence 
on homocysteine to label it as an ‘independent risk factor’. Homocysteine 
lowering interventions do not seem to be effective in preventing CVDs, as it was 
thought to have been in theory.67 This fact could probably be treated as 
‘evidence’ that homocysteine is in fact not responsible for increasing risks of 
CVD, but could be a factor that is present as a ‘produce’ from other metabolic 







9. Combined effect of smoking and coffee on the 
cardiovascular system. 
Studies have shown that caffeine intake in smokers is greater than that of none 
smokers.57,58 It has been suggested that the reason behind heavy coffee drinking 
in smokers is because nicotine present in tobacco allows the body to eliminate 
caffeine at a greater pace. Therefore, in order to get the effects of caffeine in 
the presence of nicotine in the body, more coffee or any caffeinated beverage 
needs to be consumed.59  
 
Smoking increases platelet aggregation resulting in a hypercoagulable state, 
raised fibrinogen levels and polycythaemia. Smoking also disrupts the inner 
vascular lining, causing a chroming inflammatory state resulting in 
dyslipidaemia.65 
 
According to some researches’ the combined effect of habitual coffee drinking 
and smoking could significantly place an individual at a greater risk of CVD.60 In 
an earlier study they found that smokers that drank more than 5 cups of coffee 
a day had higher levels of LDL cholesterol, and lower levels of HDL than those 
that did not smoke or drank little to no coffee. However, they were unable to 
firmly conclude that coffee consumption and smoking resulted in high LDL levels 
and lower HDL levels in the body. Instead they concluded that “there may be an 
interactive effect of smoking and consumption of coffee on lipids and 




On the bases of the separate effects of consumption of coffee and smoking, 
researches have put forward as to a combination of smoking and coffee drinking 
poses a greater risk for CVDs. The reason is that smoking and caffeine separately 
increase arterial stiffness, and there by lead to systemic hypertension. A 
combination of both could result in the impact of the two stimuli being greater 
than the sum of the separate impacts of the two stimuli alone. That is smoking 
alone can result in stiffness of arteries, and coffee alone without the 
combination of smoking could have similar effects. However, the combination of 
both is perhaps worse than the effects of one of the single stimuli.62  
 
 
10. Methodological limitations  
Limitations on the research of the effects coffee may have on the cardiovascular 
system resulting in a cardiovascular incident in coffee drinkers, exists in the 
limitations of the study designs used during the research, and my own ability to 
interpret the studies’ discussions and findings.   
The following could be classified as the general limitations of the studies used in the 
thesis:  
 Low number of RCTs;  
 Small sample sizes;  
 Differences among study populations;  
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 Measure used to collect data;  
 Introduction of researchers personal biases in literature reviews. 
 
1. Low number of RCTs:  
Randomized control trials, are a type of study design that tries to 
minimize bias through strong experimental controls. It is considered as 
the ‘gold standard’ in study designs. During the literature searches, the 
number of RCTs were fewer, compared to cohort and case control 
study designs. Due to the fewer number of RCTs available, the thesis 
mainly uses observational studies, therefore introducing more chances 
for biases.  
Table 8: Study designs used in section 7:  
Førde OH et al. (1985) (15) Randomised intervention study 
Thelle DS et al. (1976) (1983) 
(14) (16) 
Prospective cohort study 
Bønaa K et al. (1988) (17) Prospective cohort study 
Lindahl B et al. (1991) (37) Prospective cohort study 
Jacobsen BK et al. (1987) (18) Cross sectional study 
 
Observational studies were selected mainly due to the lack of availability of RCTs. 
However, cohort study design can provide information about the causation of 
disease from the time of exposure to the occurrence of the disease. With the data 
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from cohort studies, it is possible to calculate cumulative incidences, which are the 
most direct measurement of the risk of developing disease. However, the risk of bias 
is greater.  
Possible biases introduced within the thesis due to the observational study designs 
involved include:  
 Selection bias: the studies used in the thesis could be subjected to selection 
bias. The study populations involved in most of the cohort, case control and 
cross sectional studies in the thesis, come from population registries within 
certain municipalities, or from hospital registries in certain municipalities. The 
study participants were mainly chosen for the studies based on whether or 
not they drank coffee. Although other factors were considered, such as 
lifestyle, quantity of coffee consumption, some of the studies did not explain 
brewing methods used, type of coffee consumed, or additional substances 
added to the coffee such as milk/cream or sugar. While some studies used in 
the thesis, did not consider biological factors, such a genetics, and did not 
include family history of heart disease in their questionnaires.   
 Information bias: There is no direct way of knowing how much information 
bias exists in the thesis. This is because information bias results from inexact 
reporting of individual factors. Therefore, it should be considered as a factor 
that could affect the overall outcome of the results used in the thesis.  
 Measurement errors: Although there is no way of knowing the extent of 
measurement errors in the studies used in the thesis, this again should be 
considered as one of the factors that could lead to different measurement 
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inaccuracies among the different studies, but which result in similar 
outcomes. This is because even if measurement error occurs, the overall 
outcome from the effect may not change greatly.    
 Confounding: Confounding variables make it harder to analyse the study 
cohort, because the variables first need to be recognized before adjusting for 
them. For example, in the newer cohort studies, adjustments for possible 
confounders such as smoking had been made, and coffee was considered as 
either possible or not possible risk factor depending on the brewing method 
utilized. However, in the older studies confounders such as smoking was only 
partially adjusted for, which may have led to inaccurate conclusions.    
 Hawthorne effect: The Hawthorne effect is an unavoidable observation bias. 
This is when the study population modifies its behaviour because they know 
they are being observed and therefore may change their lifestyle choices, 
such as eating habits, during the study period.    
 Attrition bias: Cohort study designs require long follow up times, and 
therefore study participants could be lost to follow up.   
 Recall bias: In retrospective case control studies, the participants may report 
inaccurate information which leads to bias within the study.   
 
2. Small sample sizes:  
While some of the studies, such as the Tromsø heart study and the 
SHEEP and VHEEP study, were relatively larger prosective population 
based cohorts, the other studies used in the thesis had smaller sample 




3. Differences among study populations:  
The study population used in the thesis differ in age, gender, lifestyle, 
and origin. Studies from within the Scandic regions were preferred, 
where the participants had similar cultural and traditional 
backgrounds, but these studies were not exclusively used. While this 
increases generalization, it also increases chances for biases if the 
possible confounders were not recognized and adjusted for among the 
different study population groups.  
 
4. Measure used to collect data:  
Most of the studies used in the thesis involved questionnaires that 
were self reported. In observational study designs, while there may be 
no another alternative to obtain information about the participants, 
potential problems, such as response bias, where the participants tend 
to responde differently regardless of the actual evidence to suggest 
otherwise, may not be avoidable. Other problems include how 
differently people interpret rating scales, understand the questions, 
and their introspective ability during the answering phase.   
 
5.  Introduction of researchers personal biases in literature reviews:  
The thesis includes literature reviews. The research quality depends on 
the skills of the author to analyse and interpret the available data, and 
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there is a possiblity that the research may be have been influenced by 
the author’s personal biases during the writing process.  
 
11. Summary and Conclusion:  
Originally, the claims of coffee’s effects on cardiovascular health was based on the 
studies that had either not adjusted or partially adjusted for smoking. It was believed 
that coffee drinkers were at a higher risk of dying from a cardiovascular related cause 
than those who did not drink coffee. It was not until researchers started to 
completely adjust for smoking, did they discovered that those who smoked were also 
heavy coffee drinkers. Smokers were believed to be at a higher risk of dying from a 
cardiovascular related incident than nonsmokers.  
Researchers in Northern Norway however, had different results to that of the rest of 
the world including results from Southern Norway. While smokers still consumed 
more coffee than nonsmokers, the population in Northern Norway as a whole were 
still at a higher risk of dying due to a cardiovascular related incident than those from 
Southern Norway, especially among those that consumed coffee.13 It was not until 
the mid-1980’s, researches decided to look at the brewing methods used, and the 
type of coffee being consumed, that they discovered that consumption of boiled 
coffee (back in the days) was more common in the north than in the south. It was 
only than that they realised that the consumption of boiled coffee may have resulted 
in the elevated lipid levels in the blood, which could have increased the risks of a 
cardiovascular event in the northern population, when compared to the south. Soon 
after this discovery, they were successfully able to identify the components in boiled 
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coffee that was responsible for elevating the total cholesterol levels in the blood as 
cafestol and kahweol, the two cholesterol components of coffee. Paper filters have 
been credited to successfully filter cafestol and kahweol. 
 Over the years, the concept of coffee changed as researchers noticed that drinking 
filtered coffee did not increase the risks of CVD. They proposed that the antioxidants 
present in coffee could be of beneficial value to health in general.  
However, researchers noticed that some coffee drinkers were more susceptible to 
CVDs than others, even after adjusting for smoking. They proposed that perhaps the 
quantity of coffee being consumed resulted in the outcome of the patients’ health. It 
was discovered that drinking coffee in larger quantities led to an increase in levels of 
homocysteine in the blood. This was when homocysteine was finally suspected as a 
possible component responsible for increasing risks of CVD. Although this has been 
debated in length among the research community over recent years, homocysteine is 
no longer regarded as an independent risk factor, and homocysteine lowering 
interventions seem to not be beneficial to the outcome in CVD related cases. 
However, it can still be regarded as one among many of the secondary biomarkers to 
the risks of CVD’s. On the contrary to the believe that increased coffee intake may 
increase homocysteine, many researchers during cohort study designs, noticed that 
those that drank no or little coffee (< 3 cups a day), were more likely to experience a 
CVD related incident than those that were heavy coffee drinkers, after adjusting for 




It can be argued that the type of study design, could delegate the results of the 
studies. Some researchers have suggested that cohort study designs show very little 
risk of coronary heart disease among habitual coffee drinkers, but case-control 
studies have a tendency to suggest that risks for CVD increases among the heavier 
coffee drinkers (> 5 cups per day). This is because of possible biases present in both 
the study designs. Case control studies may also have poorer control for 
confoundings than in cohort studies, resulting in slighlty different outcomes. It has 
been suggested that the discrepancy between the findings from cohort and case-
control studies may be explained if coffee was to act as a triggering event in people 
with chronic CHD which led to MI, instead of it being a risk factor for CHD. 
It is clear that the effects of coffee on the cardiovascular system depends on the 
brewing methods as well as the quantity of consumption. Other factors such as 
lifestyle, genetics, economical background and education still play a major role in the 
outcome of cardiovascular related deaths all over the world, and coffee in itself 
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Supplementary table 1: Database and search strategy.  
 
Cardiovascular Diseases Google scholar  “Cardiovascular diseases” 
AND “Coffee” OR “Effects 
of coffee” AND “ Coffee as 
a risk factor for CVD” OR 
“Risk factors of Coffee 
drinking” AND “The 
Tromso heart study and 
coffee” AND “coffee and 
cardiovascular health 
research from 
scandinavia” AND “Coffee 
consumption on the 
heart”. 
Cardiovascular Diseases  Pubmed  (("coffee"[MeSH Terms] 
OR "coffee"[All Fields]) 
AND ("drinking"[MeSH 
Terms] OR "drinking"[All 
Fields] OR "alcohol 
drinking"[MeSH Terms] 
OR ("alcohol"[All Fields] 
AND "drinking"[All 
Fields]) OR "alcohol 
drinking"[All Fields]) AND 
("risk factors"[MeSH 
Terms] OR ("risk"[All 
Fields] AND "factors"[All 
Fields]) OR "risk 
factors"[All Fields] OR 
("risk"[All Fields] AND 
"factor"[All Fields]) OR 

















Homocysteine  Google scholar  “Homocysteine and coffee 
drinking” OR “Effects of 




“Relation of coffee 
drinking with serum 
homocysteine levels”   




("coffee"[MeSH Terms] OR 
"coffee"[All Fields]) AND 
("drinking"[MeSH Terms] 
OR "drinking"[All Fields] 
OR "alcohol 
drinking"[MeSH Terms] 
OR ("alcohol"[All Fields] 
AND "drinking"[All 
Fields]) OR "alcohol 
drinking"[All Fields])) 
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